PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis
Human Molecular Genetics · 09.06.2026 · 35 (11)
DOI: 10.1093/hmg/ddag044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 09.06.2026. Verfasst von Wen-Ye Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College o…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Protein-Arginine N-Methyltransferases, Neovascularization, Pathologic, Repressor Proteins. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Key Laboratory Construction of Hubei Province, Hubei Medical Biology International Science and Technology Cooperation Base, National Natural Science Foundation of China.
Abstract (Originalsprache)
PRMT1 is an important regulator implicated in multiple malignancies, yet its role in cervical cancer remains unclear. In this study, we investigated the functional significance of PRMT1 in cervical cancer using integrated public transcriptomic datasets, CRISPR/Cas9-edited HeLa cells, and an in vivo xenograft model. PRMT1 was upregulated in cervical cancer tissues and was associated with histological grade, clinical stage, and lymph node metastasis status, although it was not significantly associated with overall survival. In vitro, PRMT1 depletion inhibited cell proliferation, colony formation, aggregation, and migration, and was accompanied by mitochondrial apoptosis, S-phase arrest, altered c-Myc and PI3K/AKT signaling, and changes in EMT-related marker expression. Conditioned medium from PRMT1-knockout cells also impaired human umbilical vein endothelial cells (HUVECs) tube formation and was associated with reduced MMP-9 expression. In vivo, PRMT1 knockout significantly suppressed xenograft growth and reduced Ki-67 and CD31 expression. Collectively, these findings suggest that PRMT1 is an important regulator associated with cervical cancer progression and a potential candidate biomarker for prognostic assessment and therapeutic targeting, although its clinical prognostic value requires further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central Minzu University, 182 Minyuan Road, Hon…
ORCID-Profile: Lu Xue
Förderung
- Key Laboratory Construction of Hubei Province
- Hubei Medical Biology International Science and Technology Cooperation Base
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- South-Central MinZu University
Zitieren
APA
Liu, W. Y., Huang, H. W., Ma, J. N., & Xue, L. (2026). PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis. Human Molecular Genetics, 35(11). https://doi.org/10.1093/hmg/ddag044
Vancouver
Liu WY, Huang HW, Ma JN, Xue L. PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis. Human Molecular Genetics. 2026;35(11). doi:10.1093/hmg/ddag044
BibTeX
@article{Liu2026,
author = {Liu, Wen-Ye and Huang, Han-Wen and Ma, Jin-Ni and Xue, Lu},
title = {PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {11},
doi = {10.1093/hmg/ddag044}
}
EUVIMED